Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-04-06FDA Approved: CERIANNA — Supplemental Application (GE Healthcare Inc.)
The FDA approved a supplemental application for CERIANNA (fluoroestradiol F-18) from GE Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Tranexamic Acid for Alloplastic Breast Reconstruction [Phase 3]
Phase 3 trial update evaluating tranexamic acid for reducing hematoma in alloplastic breast reconstruction.
-
FDA approval · 2022-04-05FDA Approved: VIJOICE — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved VIJOICE (alpelisib) via an Original Application submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase II Study of Everolimus Beyond Progression [Phase 2]
Phase II trial evaluating Everolimus beyond progression in breast cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer [Phase 3]
Phase 3 randomized trial evaluating carboplatin and paclitaxel with or without veliparib in HER2-negative metastatic or locally advanced unr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery [Phase 2]
Phase 2 trial comparing PECS block with multimodal analgesia to prevent persistent postoperative pain after breast surgery; results were pos…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial assessing neoadjuvant therapy with pyrotinib, trastuzumab, pertuzumab, and nab-paclitaxel for HER2-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction [Phase 3]
Phase 3 clinical trial update on immunonutrition and carbohydrate loading strategies in breast reconstruction following mastectomy; study co…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive [Phase 1, Phase 2]
Phase 1/2 trial update on a T cell receptor therapy targeting MAGE-A3 in HLA-DP0401 positive metastatic cancer; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer [Phase 3]
Phase 3 study evaluating atezolizumab or placebo in combination with neoadjuvant doxorubicin + cyclophosphamide followed by paclitaxel + tra…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of KD019 and trastuzumab in HER2-positive metastatic breast cancer, terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update evaluating Immunopheresis alone or with chemotherapy versus chemotherapy alone in advanced breast cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: [Phase 2]
Phase 2 clinical trial completed evaluating IV lidocaine for patients undergoing primary breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) [Phase 2]
Phase 2 trial of trilaciclib in combination with gemcitabine and carboplatin in metastatic triple-negative breast cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer [Phase 4]
A Phase 4 clinical trial update on Inetetamab combined with anti-PD-1 antibody and albumin-bound paclitaxel for HER2-positive metastatic bre…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Study of Preoperative Boost Radiotherapy [NA]
A terminated clinical trial studying preoperative boost radiotherapy for breast cancer with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) [Phase 1, Phase 2]
Phase 1/2 trial update for an ER+/HER2- breast cancer candidate (ENZENO) in locally advanced or metastatic disease; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients [Phase 2]
Phase 2 clinical trial update evaluating nivolumab after induction treatment in triple-negative breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of talazoparib in Asian patients with metastatic breast cancer characterized by homologous …
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes
A terminated clinical trial evaluating real-world treatment patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer, with resul…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating palbociclib with fulvestrant or tamoxifen in metastatic breast cancer (hormone receptor positive) has completed rec…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of neratinib in older patients with stage IV HER2-positive breast cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16) [Phase 2]
Phase 2 trial evaluating pembrolizumab with paclitaxel in hormone receptor-positive metastatic breast cancer selected for high tumor mutatio…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating the combination of lapatinib with trastuzumab in HER2-positive metastatic breast cancer has completed. Results were…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women [Phase 2]
Phase 2 trial evaluating letrozole plus palbociclib as neoadjuvant therapy for postmenopausal women with stage II-IIIA luminal breast cancer…